Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
DESCRIPTION (provided by applicant): Endogenous opioid peptides, including proopiomelanocortin (POMC)-derived beta-endorphin, modulate neurobiological responses to ethanol and administration of ethanol alters the expression of POMC and beta- endorphin. Given that ethanol has direct effects on POMC activity, it is possible that the other POMC-derived peptides, namely the melanocortins (MCs), are also involved with neurobiological responses to ethanol. MC peptides include alpha-melanocyte stimulating hormone (alpha-MSH), which is synthesized in the arcuate nucleus of the hypothalamus, the nucleus of the solitary tract, and the medulla, regions that project to many brain regions of known relevance to alcoholism. Pre-treatment with MC receptor (MCR) agonists reduce heroin self-administration and chronic administration of morphine or cocaine increases MC-4 receptor (MC4R) levels in striatum rats. Interestingly, rats selectively bred for high ethanol consumption have abnormal levels of MC-3 receptor (MC3R) and MC4R in the nucleus accumbens (NAc) and hypothalamus, and we have provided preliminary findings indicating that intracerebroventricular (i.c.v.) infusion of a selective MC4R agonist reduces, while i.c.v. infusion of a non-selective MCR antagonist increases, ethanol drinking by C57BL/6J mice. Hence, the specific aims proposed below will test the guiding hypothesis that MCR signaling modulates ethanol consumption and neurobiological responses to ethanol. Specifically, we will determine if MC3R and/or MC4R signaling limits self-administration of ethanol by mice (Specific Aim 1), if the endogenous MCR antagonist, agouti-related protein (AgRP), promotes ethanol self-administration by mice (Specific Aim 2), if MCR agonists and antagonists influence ethanol consumption by acting on the MC3R and/or MC4R (Specific Aim 3), and if administration of ethanol will increase alpha-MSH and MC3R/MC4R levels while at the same time decrease AgRP levels, a response that could theoretically protect against uncontrolled ethanol drinking (Specific Aim 4).
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
alcoholic beverage consumptionautoradiographybehavior testbehavioral /social science research tagbiological signal transductionethanolgenetically modified animalshormone inhibitorhormone receptorhormone regulation /control mechanismimmunocytochemistrylaboratory mousemelanocyte stimulating hormoneneurobiologyneurotransmitter antagonistproopiomelanocortinreceptor expressionself medicationsubstance abuse related behavior
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
01-August-2005
Project End Date
30-June-2009
Budget Start Date
01-August-2005
Budget End Date
30-June-2006
Project Funding Information for 2005
Total Funding
$263,234
Direct Costs
$181,200
Indirect Costs
$82,034
Year
Funding IC
FY Total Cost by IC
2005
National Institute on Alcohol Abuse and Alcoholism
$263,234
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AA015148-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AA015148-01A1
Patents
No Patents information available for 1R01AA015148-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AA015148-01A1
Clinical Studies
No Clinical Studies information available for 1R01AA015148-01A1
News and More
Related News Releases
No news release information available for 1R01AA015148-01A1
History
No Historical information available for 1R01AA015148-01A1
Similar Projects
No Similar Projects information available for 1R01AA015148-01A1